UnitedHealth Group Optum Rx — Restructuring Costs remained flat by 0.0% to $97.25M in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
High restructuring costs signal active operational transformation, which may lead to future margin expansion but indicates current organizational friction.
This metric captures the expenses incurred by the business segment to reorganize its operations, workforce, or internal...
Comparable to 'Restructuring charges' or 'Transformation costs' reported by diversified healthcare and pharmacy services companies during periods of strategic realignment.
unh_segment_optum_rx_restructuring_costs| FY'25 | |
|---|---|
| Value | $389.00M |
We use cookies for analytics. See our Privacy and Cookie Policy.